GPCR Drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
72
NCT05748119
A Study to Assess the Safety of MEB-1170 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 15, 2022
Completion: Oct 1, 2023
Loading map...